Results 151 to 160 of about 253,625 (250)

Radionuklidtherapie von Knochenmetastasen mittels Radium-223. DGN-Handlungsempfehlung

, 2016
This document describes the guideline for therapy of bone metastases with radium-223 ((223)Ra) published by the Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften in Germany (AWMF) under the auspices of the Deutsche Gesellschaft ...
Pöppel, Thorsten D, Krause, Thomas, Becherer, Alexander, Geworski, Lilli, Krause, Bernd J, Gabriel, Michael, Sonnenschein, Wilfried, Schenck, Marcus, Heinzel, Alexander, Fricke, Eva, Andreeff, Michael, Bockisch, Andreas, Pöppel, Thorsten D., Krause, Bernd J., Scheidhauer, Klemens, Krause, Thomas Michael, Mitterhauser, Markus   +16 more
core   +1 more source

The Age at Onset of LRRK2 p.Gly2019Ser Parkinson's Disease Across Ancestries and Countries of Origin

Annals of Neurology, Volume 99, Issue 6, Page 1394-1404, June 2026.
Objectives The objective of this study was to elucidate differences in the cumulative incidence of Leucine‐rich repeat kinase 2 (LRRK2) p.Gly2019Ser‐related Parkinson's disease (PD; LRRK2‐PD) between ancestries and countries. Methods We included 922 unrelated p.Gly2019Ser variant carriers (affected = 762 and unaffected = 160) from the Global Parkinson ...
Theresa Lüth, Björn‐Hergen Laabs, Sebastian Sendel, Inke R. König, Amke Caliebe, Alastair J. Noyce, Laurel A. Screven, Soraya Bardien, Matthew Farrer, Faycel Hentati, Rim Amouri, Christine Klein, Samia Ben Sassi, Joanne Trinh, Global Parkinson's Genetics Program (GP2)   +14 more
wiley   +1 more source

The Romance of Radium

, 1920
A full color pamphlet published in 1920 by the Radium Dial Company depicting the discovery, extraction and use of radium in home and industrial ...
Radium Dial Company
core  

Discrimination of Lipid Hydroperoxide Positional Isomers Using SFC– MS/MS With Sodium Ion: Its Application to Evaluating the Oxidation Mechanisms of Oxidized Oils

Journal of the American Oil Chemists' Society, Volume 103, Issue 6, Page 623-632, June 2026.
ABSTRACT Advanced lipid profiling relies on liquid chromatography–tandem mass spectrometry (LC–MS/MS), but long analysis times remain a challenge. Supercritical fluid chromatography (SFC)–MS/MS using supercritical carbon dioxide offers a faster and more environmentally friendly alternative.
Ryosuke Aoki, Masayoshi Sakaino, Junya Ito, Shunji Kato, Jun Imagi, Toshiro Sato, Kiyotaka Nakagawa   +6 more
wiley   +1 more source

Radium Emanation Therapy, advertisement

, 1900
A flyer advertising radium enriched vessels for the dispensing of radon-infused water (emanation therapy) available from Radium Limited, U.S.A ...
Radium Limited, U.S.A.
core  

Extracellular Vesicles as Drivers of Lung Endothelial Dysfunction in ARDS: Mechanisms and Therapeutic Opportunities

Comprehensive Physiology, Volume 16, Issue 3, June 2026.
This review summarizes how extracellular vesicles from diverse pulmonary and extrapulmonary sources contribute to endothelial dysfunction in ARDS and evaluates emerging endothelial‐targeted therapies for their potential to mitigate EV‐mediated pathogenic mechanisms.
Mohammed Yaman Al Matni, Patrick Belvitch, Steven M. Dudek, Eleftheria Letsiou   +3 more
wiley   +1 more source

Radium-223 in Heavily Pretreated Metastatic Castrate-Resistant Prostate Cancer

, 2016
BACKGROUND: Radium-223 is a bone-targeting radiopharmaceutical that extends survival in mCRPC. Postapproval data are limited, and the value of biochemical and radiologic monitoring during radium therapy is unknown.
Hwang, Clara, Heath, Elisabeth I, Modi, Dipenkumar, Joyrich, Richard, Vaishampayan, Ulka, Mamdani, Hirva, Gayar, Hesham, Kim, Seongho   +7 more
core  

Radium-223 for the treatment of castration-resistant prostate cancer

, 2015
The vast majority of patients with metastatic castration-resistant prostate cancer (mCRPC) develop bone metastases. Bone metastases are a source of significant morbidity and affect quality of life in these patients.
El-Amm, Joelle, Aragon-Ching, Jeanny B.
core   +1 more source

Research Progress in the Preparation Technology of Radium-223

Journal of Isotopes
223Ra is a low toxicity substance α Radiotherapy nuclide, which can be used to treat castrated resistant prostate cancer (CRPC) with symptoms of bone metastasis and no visceral metastasis, was the first approved alpha therapy radiopharmaceutical on the ...
Junshan GENG, Jianrong WU, Qian XIAO, Bo LI, Yunming CHEN, Jingsong ZHANG, Ning LUO   +6 more
doaj   +1 more source

Fatal Pancytopenia Associated with Radium-223 Dichloride in a Patient with Castration-Resistant Prostate Cancer and Multiple Bone Metastases

Case Reports in Clinical Practice, 2018
Radium-223 dichloride (Ra-223) is an alpha-emitting radioisotope that targets osteoblastic metastasis of prostate cancer. For Ra-223, a favorable safety profile has been described.
Yukihiro Hama, shoji koga
doaj